Skip to main content
EMBC logo

EMBC · Embecta Corp. · Webcasts, Transcripts & Audio

Track EMBC — free
$6.17 +0.02 (+0.33%) Play latest call Q3 2026 earnings call transcript
Market Cap
$348.46M
Shares
56.66M
Volume · Nov 18 186.52K Avg daily vol (3M) 1.04M

Embecta Corp. Webcasts

Earnings calls, investor updates, investor days and conferences for Embecta Corp. (EMBC), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Earnings call
FY26 · Q3
2026-08-07
Embecta Corp. (EMBC) Q3 2026 Earnings Call Transcript
Positive tone Owen Mumford acquisition and integration Year-over-year revenue decline Sequential financial improvement
Revenue
$271.70M
▼ 8.1% YoY
Diluted EPS
$0.36
▼ 53.8% YoY
Gross margin
56.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q2
2026-05-05
Embecta Corp. (EMBC) Q2 2026 Earnings Call Transcript
Cautious tone Q2 revenue shortfall and U.S. business underperformance Owen Mumford acquisition International business and China outlook
Revenue
$221.80M
▼ 14.4% YoY
Diluted EPS
$-0.07
▼ 117.5% YoY
Gross margin
57.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY26 · Q1
2026-02-05
Embecta Corp. (EMBC) Q1 2026 Earnings Call Transcript
Positive tone FY2026 guidance and pricing dynamics GLP-1 partnership strategy Strategic roadmap and seed growth phase
Revenue
$261.20M
▼ 0.3% YoY
Diluted EPS
$0.74
Gross margin
61.9%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q4
2025-11-25
Embecta Corp. (EMBC) Q4 2025 Earnings Call Transcript
Positive tone Revenue Decline GLP-1 Strategy China Headwinds
Revenue
$264.00M*
▼ 7.7% YoY
Gross margin
60.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY25 · Q3
2025-08-08
Embecta Corp. (EMBC) Q3 2025 Earnings Call Transcript
Positive tone Debt reduction and financial flexibility GLP-1 pen-needle opportunity Product portfolio and retail expansion
Revenue
$295.50M
▲ 8.4% YoY
Diluted EPS
$0.78
▲ 212% YoY
Gross margin
66.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q2
2025-05-09
Embecta Corp. (EMBC) Q2 2025 Earnings Call Transcript
Positive tone Revenue Performance and Guidance Tariffs US Retail Pharmacy Customer / Store Closures
Revenue
$259.00M
▼ 9.8% YoY
Diluted EPS
$0.40
▼ 20% YoY
Gross margin
63.4%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-02-06
Embecta Corp. (EMBC) Q1 2025 Earnings Call Transcript
Positive tone Revenue decline and tough comps Product portfolio expansion and partnerships FX headwind on guidance
Revenue
$261.90M
▼ 5.6% YoY
Diluted EPS
$0.00
▼ 100% YoY
Gross margin
60.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q4
2024-11-26
Embecta Corp. (EMBC) Q4 2024 Earnings Call Transcript
Cautious tone Separation from BD Core business and Medicare contracts Patch pump discontinuation
Revenue
$286.10M*
▲ 1.5% YoY
Gross margin
60.7%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY24 · Q3
2024-08-09
Embecta Corp. (EMBC) Q3 2024 Earnings Call Transcript
Positive tone Separation and ERP implementation Core injection business performance GLP-1 administration and pen needles
Revenue
$272.50M
▼ 4.8% YoY
Diluted EPS
$0.25
▼ 3.8% YoY
Gross margin
69.8%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q2
2024-05-09
Embecta Corp. (EMBC) Q2 2024 Earnings Call Transcript
Positive tone Revenue growth and Q2 performance Competitive risk: weekly basal insulin / GLP-1s Insulin patch pump program (open- and closed-loop)
Revenue
$287.20M
▲ 3.6% YoY
Diluted EPS
$0.50
▲ 108.3% YoY
Gross margin
64.6%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-02-09
Embecta Corp. (EMBC) Q1 2024 Earnings Call Transcript
Positive tone Q1 financial results and raised guidance Separation from former parent / standalone infrastructure Insulin patch pump program (Type 2)
Revenue
$277.30M
▲ 0.6% YoY
Diluted EPS
$0.35
▼ 42.6% YoY
Gross margin
67.0%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2023-11-21
Embecta Corp. (EMBC) Q4 2023 Earnings Call Transcript
Revenue
$281.90M*
▲ 2.7% YoY
Gross margin
64.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-08-08
Embecta Corp. (EMBC) Q3 2023 Earnings Call Transcript
Revenue
$286.10M
▼ 1.7% YoY
Diluted EPS
$0.26
▼ 75.7% YoY
Gross margin
66.2%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-05-12
Embecta Corp. (EMBC) Q2 2023 Earnings Call Transcript
Revenue
$277.10M
▲ 0.9% YoY
Diluted EPS
$0.24
▼ 82.6% YoY
Gross margin
68.5%
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-02-14
Embecta Corp. (EMBC) Q1 2023 Earnings Call Transcript
Revenue
$275.70M
▼ 4.7% YoY
Diluted EPS
$0.61
▼ 64.7% YoY
Gross margin
68.5%
Rev · 7q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2022-12-20
Embecta Corp. (EMBC) Q4 2022 Earnings Call Transcript
Revenue
$274.60M*
▼ 8.7% YoY
Gross margin
64.4%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-08-15
Embecta Corp. (EMBC) Q3 2022 Earnings Call Transcript
Revenue
$291.10M
▼ 1.3% YoY
Diluted EPS
$1.07
▼ 40.9% YoY
Gross margin
69.7%
Rev · 6q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-05-13
Embecta Corp. (EMBC) Q2 2022 Earnings Call Transcript
Revenue
$274.50M
▼ 3.4% YoY
Diluted EPS
$1.38
▼ 26.2% YoY
Gross margin
69.7%
Rev · 5q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Showing 1–18 of 18 webcasts
Key facts CIK 1872789 CUSIP 29082K105 13F (30d) 341 filings 288 filers Visit website Investor relations